Elevated FSP1 Protects KRAS-Mutated Cells from Ferroptosis during Tumor Initiation

The authors found that pharmacological induction of ferroptosis in pancreatic organoids derived from the LsL-KRASG12D expressing mouse model was only effective in combination with FSP1 inhibition.